Viamet Pharmaceuticals Holdings, LLC

Overview

Viamet Pharmaceuticals, Inc., a private biotechnology company, specializes in the discovery, development, and commercialization of novel therapeutics for the treatment of diseases caused by fungal infections. The company's proprietary metalloenzyme platform allows for the identification of next-generation drugs that address the limitations of existing therapies.

Therapeutic areas

Infectious DiseasesAntifungal Therapies

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Viamet Pharmaceuticals Holdings, LLC in our records. PharmaTek screens the full directory against live FDA enforcement data.

Verified Supplier Partner

Is this Viamet Pharmaceuticals Holdings, LLC? Get in front of buyers actively sourcing.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.